Albie Lavin is the inventor of the Impel Pharmaceuticals I143 device, the first nasal spray developed around the use of a single-use compressed gas cylinder.

Mr Lavin has spent the last five years developing novel nasal spray devices designed to achieve precision olfactory delivery, including combination products indicated for acute agitation, Parkinson’s disease and migraine.

He currently serves as a Technical Advisory Consultant to Picocyl and remains passionate about developing novel device solutions for the drug delivery space.

More contributions